Suppr超能文献

老年人接种新冠疫苗后针对严重急性呼吸综合征冠状病毒2的体液免疫和细胞免疫反应:一项系统综述

Humoral and Cellular Immune Responses Against SARS-CoV-2 Following COVID-19 Vaccination in Older Adults: A Systematic Review.

作者信息

la Cruz Ruth Angélica Rojas-De, Flores-Córdova Janeth M, Calderon-Hernandez Cielo Cinthya, Cahuapaza-Gutierrez Nelson Luis, Ccallalli-Ruiz Nino Arturo, Runzer-Colmenares Fernando M

机构信息

Facultad de Ciencias de la Salud, Carrera de Medicina Humana, Universidad Científica del Sur, Lima 15067, Peru.

CHANGE Research Working Group, Universidad Científica del Sur, Lima 15067, Peru.

出版信息

Vaccines (Basel). 2025 Aug 12;13(8):852. doi: 10.3390/vaccines13080852.

Abstract

BACKGROUND

Evidence on the humoral and cellular immune responses to SARS-CoV-2 following COVID-19 vaccination in older adults is warranted.

AIMS

To synthesize and analyze the current evidence on humoral and cellular immune responses to both standard and booster COVID-19 vaccination in individuals aged 60 years and older.

METHODS

Clinical trials and observational studies were included. Reviews, case series, letters to the editor, and similar publications were excluded. A selective literature search was conducted in the following databases: PubMed, Scopus, EMBASE, and Web of Science. The risk of bias and methodological quality of the included studies were assessed using the Newcastle-Ottawa Scale (NOS) and the Risk of Bias 2.0 (RoB 2) tool. Statistical analysis was conducted using Stata version 18 and Review Manager version 5.4.1.

RESULTS

Thirteen studies were included: eleven observational studies and two randomized clinical trials, evaluating humoral and cellular immune responses in 782 older adults. Messenger RNA vaccines were the most administered, particularly Pfizer-BioNTech (76.9%) and Moderna mRNA-1273 (23%). In most cases, immune responses were assessed after the second dose and booster doses. Most studies (61.5%) reported increased IgG titers specific to the SARS-CoV-2 Spike protein, while 23.1% reported a decrease. Regarding cellular immunity, 46.2% of the studies reported low interferon-gamma (IFN-γ) levels post-vaccination, whereas 38.5% showed increases. These findings highlight the need for tailored vaccination strategies to address emerging variants, particularly in vulnerable populations such as older adults.

CONCLUSIONS

In older adults receiving COVID-19 vaccination, humoral immunity tends to increase, whereas cellular responses are frequently diminished, reflecting age-related immunosenescence that may limit the durability and breadth of protection following vaccination in older adults.

摘要

背景

需要有关老年人接种新冠病毒疫苗后对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的体液免疫和细胞免疫反应的证据。

目的

综合分析60岁及以上人群对标准剂量和加强剂量新冠病毒疫苗的体液免疫和细胞免疫反应的现有证据。

方法

纳入临床试验和观察性研究。排除综述、病例系列、致编辑的信及类似出版物。在以下数据库进行了选择性文献检索:PubMed、Scopus、EMBASE和科学网。使用纽卡斯尔-渥太华量表(NOS)和偏倚风险2.0(RoB 2)工具评估纳入研究的偏倚风险和方法学质量。使用Stata 18版和Review Manager 5.4.1版进行统计分析。

结果

纳入13项研究:11项观察性研究和2项随机临床试验,评估了782名老年人的体液免疫和细胞免疫反应。信使核糖核酸(mRNA)疫苗使用最为广泛,尤其是辉瑞-BioNTech(76.9%)和莫德纳mRNA-1273(23%)。在大多数情况下,在第二剂和加强剂接种后评估免疫反应。大多数研究(61.5%)报告针对SARS-CoV-2刺突蛋白的IgG滴度升高,而23.1%报告下降。关于细胞免疫,46.2%的研究报告接种疫苗后干扰素-γ(IFN-γ)水平较低,而38.5%显示升高。这些发现凸显了针对新出现的变异株制定个性化疫苗接种策略的必要性,尤其是在老年人等脆弱人群中。

结论

在接种新冠病毒疫苗的老年人中,体液免疫趋于增强,而细胞反应往往减弱,这反映了与年龄相关的免疫衰老,可能会限制老年人接种疫苗后保护的持久性和广度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f3/12389793/18655fab6d84/vaccines-13-00852-g0A1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验